Allergy Therapeutics appoints Nick Wykeman as finance director
Mr. Wykeman was most recently at Skyepharma PLC until August 2015 where he was the Group Financial Controller for six years.
Prior to that, he had also worked at Quest International (a part of ICI PLC) as the Group Financial Controller (Special Projects), following six years at Deloitte & Touche.
Mr. Wykeman has a BSc (Hons) in Economics and is a qualified accountant, being a member of the Institute of Chartered Accountants of England and Wales. ■
LATEST MOVES FROM United Kingdom
- Red Leopard appoints Toby Hayward as CEO
- Numis Corporation appoints non-executive chairman
- Avanti Communications names Alan Paul Harper as director
- Sage Group appoints Cath Keers as director
- Mothercare appoints Gillian Kent to board
More inside POST